DrugPatentWatch Database Preview
Drugs in Development Information for Tesetaxel
Email this page to a colleague
What is the development status for investigational drug Tesetaxel?
Tesetaxel is an investigational drug.
There have been 16 clinical trials for Tesetaxel.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.
The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Melanoma. The leading clinical trial sponsors are Genta Incorporated, Odonate Therapeutics, Inc., and Odonate Therapeutics, LLC.
There are six hundred and twenty-nine US patents protecting this investigational drug and five international patents.
Summary for Tesetaxel
| US Patents | 629 |
| International Patents | 5,964 |
| US Patent Applications | 1,305 |
| WIPO Patent Applications | 913 |
| Japanese Patent Applications | 536 |
| Clinical Trial Progress | Phase 2 (2017-12-01) |
| Vendors | 9 |
Recent Clinical Trials for Tesetaxel
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors | Odonate Therapeutics, Inc. | Phase 1 |
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC | Odonate Therapeutics, Inc. | Phase 2 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC | Odonate Therapeutics, Inc. | Phase 2 |
Clinical Trial Summary for Tesetaxel
Top disease conditions for Tesetaxel
Top clinical trial sponsors for Tesetaxel
US Patents for Tesetaxel
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tesetaxel | Get Started Free | Heat shock protein 70 (hsp-70) receptor ligands | Duke University (Durham, NC) | Get Started Free |
| Tesetaxel | Get Started Free | Compounds and their methods of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | Get Started Free |
| Tesetaxel | Get Started Free | Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use | Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) | Get Started Free |
| Tesetaxel | Get Started Free | Pyrrolidinone derivatives as MetAP-2 inhibitors | Merck Patent GmbH (Darmstadt, DE) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tesetaxel
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tesetaxel | World Intellectual Property Organization (WIPO) | WO2015148714 | 2034-03-25 | Get Started Free |
| Tesetaxel | Australia | AU2015231053 | 2034-03-21 | Get Started Free |
| Tesetaxel | Brazil | BR112016021620 | 2034-03-21 | Get Started Free |
| Tesetaxel | Canada | CA2943339 | 2034-03-21 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
